Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Vitamin D Induction in Optic Neuritis
NCT03302585Phase 2Terminated
- Sponsor
- University of Calgary
- Start
- Nov 2017
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin d in optic neuritis (ON), sponsored by University of Calgary. Started Nov 2017; status: terminated.
02
Drugs
vitamin d
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT03302585.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03302585.